MARIELLA PURVIS: Open Payments
NPI 1023179751 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,020 in 141 payments from 21 companies in 2025. Trend: 2023 $3,324 · 2024 $3,100 · 2025 $3,020
Food & beverage: $3,015Education: $5
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 20 | $499 |
| PFIZER INC. | 12 | $348 |
| ABBVIE INC. | 21 | $320 |
| Novartis Pharmaceuticals Corporation | 8 | $237 |
| E.R. Squibb & Sons, L.L.C. | 16 | $201 |
| Galderma Laboratories, L.P. | 9 | $194 |
| Incyte Corporation | 11 | $175 |
| Amgen Inc. | 10 | $147 |
| Regeneron Healthcare Solutions, Inc. | 6 | $141 |
| Lilly USA, LLC | 6 | $133 |
Products named: Bimzelx, CIBINQO, DUPIXENT, Sotyktu, SKYRIZI, OPZELURA, OTEZLA, NEMLUVIO.
Industry payments across DC — which companies pay providers there.
